Quidel News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.04.21	Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing (Businesswire)
01.04.21	Quidel’s QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing (Businesswire)
31.03.21	März 2021: Experten empfehlen Quidel-Aktie mehrheitlich zum Kauf (finanzen.net)
18.03.21	Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing (Businesswire)
03.03.21	FDA Accelerates Efforts To Issue EUA For More COVID-19 Home Tests (RTTNews)
01.03.21	Quidel Receives Emergency Use Authorization for QuickVue® At-Home COVID-19 Test (Businesswire)
22.02.21	Quidel to Present at Upcoming Conferences (Businesswire)
18.02.21	Quidel Reports Fourth Quarter and Full Year 2020 Financial Results (Businesswire)
16.02.21	Ausblick: Quidel legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
09.02.21	QIAGEN-Aktie stärker: Quidel prüft anscheinend Zusammenschluss (AWP) Nur wenige Monate nach der gescheiterten Übernahme durch den US-Laborausrüster Thermo Fisher Scientific scheint QIAGEN wieder in das Fadenkreuz eines Unternehmens geraten zu sein.» mehr
09.02.21	US-Unternehmen Quidel hat Interesse an Qiagen - Agentur (Dow Jones)
03.02.21	Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19 (Businesswire)
03.02.21	Erste Schätzungen: Quidel verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
28.01.21	Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021 (Businesswire)
07.01.21	Quidel Announces Preliminary Revenue for Fourth Quarter 2020; Will Present Virtually at 39th Annual J.P. Morgan Healthcare Conference (Businesswire)
23.12.20	Quidel Receives Emergency Use Authorization for Moderately Complex Solana® SARS Molecular Test for COVID-19 Diagnosis (Businesswire)
21.12.20	Quidel Receives Emergency Use Authorization for QuickVue® SARS Rapid Antigen Test for COVID-19 Diagnosis (Businesswire)
11.12.20	Quidel Corporation CEO Douglas Bryant Named Executive of the Year in MedTech Dive Awards For 2020 (Businesswire)
11.11.20	Quidel to Present at Upcoming Conferences (Businesswire)
03.11.20	Quidel to Host Virtual Investor Day on November 12, 2020 (Businesswire)
29.10.20	Quidel Reports Third Quarter 2020 Financial Results (Businesswire)
28.10.20	Ausblick: Quidel legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
19.10.20	Quidel to Hold Third Fiscal Quarter 2020 Financial Results Conference Call on October 29th, 2020 (Businesswire)
03.10.20	Quidel Receives Emergency Authorization for First Rapid Antigen "ABC Test”: A Combination Diagnostic Assay for Influenza A+B and COVID-19 (Businesswire)
01.10.20	Stock Alert: Quidel Corporation Advances 5% (RTTNews)
01.10.20	Quidel Announces Preliminary Revenue for Third Quarter 2020 (Businesswire)
29.09.20	Quidel Corporation Statement on President Trump’s Announcement of Coronavirus Testing Strategy (Businesswire)
27.08.20	Quidel Provides Business Update at 13th Annual Piper Sandler Med-Tech and Diagnostic California Bus Tour; Another SARS Antigen Entrant Does Not Change Quidel’s Strategy (Businesswire)
27.08.20	Quidel to Present Today at 13th Annual Piper Sandler Med-Tech and Diagnostics California Bus Tour (Businesswire)
27.08.20	Stock Alert: Quidel Tumbles 34% (RTTNews)
20.08.20	Quidel Concludes Sofia® SARS Antigen Investigation From Vermont (Businesswire)
20.08.20	Quidel to Update Packaging of Point-of-Care Sofia® SARS Antigen Test for COVID-19 to Include Either Nasal or Nasopharyngeal Swabs (Businesswire)
13.08.20	Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Health Canada Authorization (Businesswire)
11.08.20	CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs (RTTNews)
11.08.20	State of Maryland Allows Point-of-Care Testing for COVID-19; Quidel Expands Training Program (Businesswire)
30.07.20	Quidel Reports Second Quarter 2020 Financial Results (Businesswire)
29.07.20	Quidel to Present Virtually at the Canaccord Genuity 40th Annual Growth Conference (Businesswire)
29.07.20	Ausblick: Quidel verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
15.07.20	Erste Schätzungen: Quidel vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
14.07.20	Quidel to Hold Second Fiscal Quarter 2020 Financial Results Conference Call on July 30th, 2020 (Businesswire)
06.07.20	Quidel Announces Preliminary Revenue for Second Quarter 2020 (Businesswire)
12.06.20	Quidel Receives BARDA Funding to Develop Point-of-Care Diagnostic Assay That Includes COVID-19 (Businesswire)
11.06.20	Quidel Announces Jack Schuler Will Retire From Quidel’s Board of Directors (Businesswire)
10.06.20	Quidel Receives Amended Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay Using Sofia 1 Instrument (Businesswire)
26.05.20	Quidel to Present Virtually at William Blair 40th Annual Growth Stock Conference (Businesswire)
19.05.20	Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Emergency Use Authorization and CE Mark for Molecular Detection of COVID-19, Without Extraction Step (Businesswire)
11.05.20	Stock Alert: Quidel Stock Up 20% As FDA Approves New Antigen Test For COVID-19 (RTTNews)
09.05.20	Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	125.85	2.57 %	K V
Sika	232.30	1.84 %	K V
Swiss Re	132.20	1.58 %	K V
Logitech Intl	72.56	1.48 %	K V
ABB	51.02	1.47 %	K V
Nestle	76.60	0.16 %	K V
Sonova Hldg	300.80	0.00 %	K V
Novartis	93.14	-0.14 %	K V
Swisscom	507.00	-0.29 %	K V
Alcon	78.06	-0.41 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Quidel Corp.

Aktien Top/Flop

Quidel Peer Group Nachrichten

Meistgelesene Nachrichten